Berkeley Lights Announces Webcast of Third Quarter Financial Results on November 12, 2020
Berkeley Lights, Inc. (Nasdaq: BLI) will announce its third-quarter 2020 financial results on November 12, 2020, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Berkeley Lights, Inc. (Nasdaq: BLI) will announce its third-quarter 2020 financial results on November 12, 2020, after market close. A conference call with management will follow at 1:30 p.m. PT / 4:30 p.m. ET, accessible via the company's website. Berkeley Lights focuses on Digital Cell Biology, offering a platform for rapid development of biotherapeutics by capturing extensive data on single cells. The platform aims to standardize processes in the cell-based product value chain.
Positive
- Leading position in Digital Cell Biology with comprehensive platform offerings.
- Potential for significant advancements in biotherapeutics through enhanced cell analysis.
Negative
- No specific financial data or performance metrics available ahead of the earnings report.
Details
News Market Reaction – BLI
The recorded move for BLI in the trading session of this news was +4.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be report financial results for the third quarter 2020 after market close on Thursday, November 12, 2020. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the Company’s website at: www.berkeleylights.com. The webcast will be archived and available for replay after the event.
About Berkeley Lights
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.
Berkeley Lights’ Beacon and Lightning systems and Culture Station instrument are: FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.
Press Contact
berkeleylights@bulleitgroup.com
Investor Contact
ir@berkeleylights.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.